HBK Sorce Advisory’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,289
| Closed | -$507K | – | 596 |
|
|
2021
Q4 | $507K | Sell |
4,289
-135
| -3% | -$16K | 0.03% | 324 |
|
|
2021
Q3 | $593K | Sell |
4,424
-46
| -1% | -$6.17K | 0.03% | 294 |
|
|
2021
Q2 | $724K | Buy |
4,470
+1,976
| +79% | +$320K | 0.04% | 254 |
|
|
2021
Q1 | $200K | Buy |
+2,494
| New | +$200K | 0.01% | 513 |
|
|
2019
Q1 | – | Sell |
-10,367
| Closed | -$142K | – | 434 |
|
|
2018
Q4 | $142K | Buy |
10,367
+660
| +7% | +$9.04K | 0.02% | 369 |
|
|
2018
Q3 | $278K | Buy |
9,707
+2,126
| +28% | +$60.9K | 0.03% | 309 |
|
|
2018
Q2 | $207K | Buy |
+7,581
| New | +$207K | 0.02% | 361 |
|